Lori J Wirth Selected Research

Lori J Wirth Research Topics

Disease

40	Neoplasms (Cancer) 10/2022 - 04/2006
33	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 03/2008
13	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2003
9	medullary Thyroid cancer 01/2022 - 08/2009
9	Squamous Cell Carcinoma of Head and Neck 08/2019 - 06/2003
7	Papillary Thyroid Cancer 01/2021 - 03/2015
7	Anaplastic Thyroid Carcinoma 01/2021 - 05/2012
6	Disease Progression 01/2021 - 08/2009
6	Carcinoma (Carcinomatosis) 12/2020 - 11/2007
5	Fatigue 10/2022 - 10/2013
5	Diarrhea 01/2022 - 10/2013
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2021 - 04/2006
4	Hypertension (High Blood Pressure) 01/2020 - 02/2015
3	Nausea 10/2022 - 10/2013
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2015 - 07/2006
2	Oropharyngeal Neoplasms 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2003
2	Hyponatremia 01/2020 - 12/2016
2	Stroke (Strokes) 01/2018 - 08/2017
2	Transient Ischemic Attack 01/2018 - 08/2017
2	Asthenia 04/2017 - 02/2015
2	Carcinoid Tumor (Carcinoid) 11/2014 - 05/2004
2	Rare Diseases (Rare Disease) 10/2013 - 07/2011
2	Esophageal Stenosis (Esophageal Stricture) 08/2011 - 12/2008
2	Xerostomia 08/2011 - 12/2008
2	Pathologic Constriction (Stenosis) 11/2008 - 11/2004
1	Hyperglycemia 10/2022
1	Dermatitis 10/2022
1	Fever (Fevers) 10/2022
1	Skin Diseases (Skin Disease) 10/2022
1	Chills 10/2022
1	Fistula 01/2022
1	Chylous Ascites 01/2022
1	Chylothorax 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Thyroid Nodule (Nodule, Thyroid) 01/2019
1	Ischemic Stroke 01/2018

Drug/Important Bio-Agent (IBA)

12	lenvatinibIBA 01/2022 - 01/2015
8	IodineIBA 10/2022 - 04/2013
7	cabozantinibIBA 01/2021 - 07/2011
6	selpercatinibIBA 01/2022 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2003
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2013
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2014
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 08/2009
4	Docetaxel (Taxotere)FDA Link 10/2016 - 05/2003
3	dabrafenibIBA 10/2022 - 03/2015
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 04/2015
3	vandetanib (ZD6474)IBA 01/2021 - 12/2014
3	Iodine-131IBA 01/2020 - 01/2014
3	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 08/2009
3	LigandsIBA 12/2017 - 03/2015
3	Cisplatin (Platino)FDA LinkGeneric 10/2016 - 04/2015
3	motesanib diphosphateIBA 05/2013 - 07/2008
2	Pharmaceutical PreparationsIBA 10/2022 - 12/2016
2	pralsetinibIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2022
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 06/2003
2	Monoclonal AntibodiesIBA 10/2020 - 10/2016
2	Sorafenib (BAY 43-9006)FDA Link 10/2017 - 12/2014
2	Cetuximab (Erbitux)FDA Link 04/2016 - 02/2006
2	Celecoxib (Celebrex)FDA Link 03/2014 - 10/2005
2	Sunitinib (Sutent)FDA Link 05/2012 - 08/2010
2	Gefitinib (Iressa)FDA Link 03/2008 - 10/2005
2	BariumIBA 06/2006 - 11/2004
1	AZD 6244IBA 10/2022
1	trametinibIBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2021
1	pembrolizumabIBA 01/2021
1	larotrectinibIBA 01/2021
1	prolinedithiocarbamate (PDTC)IBA 12/2020
1	human ERBB2 proteinIBA 10/2020
1	spartalizumabIBA 10/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	VaccinesIBA 08/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 08/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Estrogen Receptor alphaIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2018
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018
1	AntibodiesIBA 01/2018
1	P-2 (P 2)IBA 01/2018
1	Thyroglobulin FDA Link 01/2018

Therapy/Procedure

34	Therapeutics 01/2022 - 11/2004
11	Radiotherapy 01/2021 - 05/2003
10	Drug Therapy (Chemotherapy) 12/2021 - 05/2004
6	Chemoradiotherapy 05/2012 - 05/2004
3	Aftercare (After-Treatment) 05/2013 - 06/2006
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2012 - 11/2008
3	Induction Chemotherapy 12/2008 - 08/2005
2	Precision Medicine 01/2019 - 01/2018
2	Chemoprevention 03/2014 - 06/2003
1	Thyroidectomy 01/2018